Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 2009
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemiaGiuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.
Microvascular Research|April 3, 2010
Effects of a standardized oral fat load on vascular remodelling markers in healthy subjectsGiuseppe Derosa, Ilaria Ferrari, Angela D'Angelo, et al.
Primary Care Diabetes|July 1, 2022
COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adultsGiacomo Pietro Vigezzi, Paola Bertuccio, Camilla Bonfadini Bossi, et al.
Clinical Drug Investigation|December 14, 2006
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose toleranceGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 26, 2007
Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metforminGiuseppe Derosa, Elena Fogari, Arrigo F G Cicero, et al.
International Journal of General Medicine|July 1, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
Archives of Medical Research|April 1, 2008
Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metforminGiuseppe Derosa, Sibilla A T Salvadeo, Angela D'Angelo, et al.
Clinical Therapeutics|July 25, 2006
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trialGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2007
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alphaGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Pharmacological Research|December 4, 2018
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT studyGiuseppe Derosa, Pamela Maffioli, Laura Scelsi, et al.
Pageof 25